1. ARRHYTHMIAS (clinical), general
1.1. Electrocardiography
1.2. Ambulatory ECG (Holter)
1.3. Programmed stimulation
1.4. Signal averaged ECG
1.5. Antiarrhythmic drugs (clinical)
1.6. Non-pharmacological therapy, general
1.7. Catheter ablation
1.8. Sudden death
1.9. Wolff-Parkinson-White syndrome
1.10. Heart rate & QT variability baroreceptors
1.11. Defibrillation, general
1.12. Automatic Implantable. Cardioverter/Defribillator
1.13. Supraventricular arrhythmias
1.14. Ventricular arrhythmias
1.15. Conduction system
2. ARRHYTHMIAS (mechanisms), general
2.1. Disturbances in impulse formation
2.2. Disturbances in impulse conduction
2.3. Mapping (experimental & clinical)
2.4. Antirrhythmic drugs, experimental studies
2.5. Autonomic nervous system, experimental studies
2.6. Arrhythmias in ischaemia & infarction (experimental)
2.7. Arrhythmias in Hypertrophy & heart failure (experimental)
3. AUTONOMIC NERVOUS SYSTEM, general
4. BLOOD VESSELS (basic research), general
4.1. Endothelium
4.2. Vascular smooth muscle
4.3. Flow in intact vessels
4.4. Local control mechanisms
4.5. Angiogenesis
4.6. Microvessels
4.7. Collaterals
5. CARDIAC CELLULAR BIOLOGY (basic research), general
5.1. Structure
5.2. Isolated myocytes
5.3. Metabolism
5.4. Ischaemia
5.5. Myocardial protection
5.6. Myocardial Hypertrophy
5.7. Molecular biology
5.8. Cardiomyopathy, myocarditis
5.9. Myocardial Membranes
5.10. Excitation/contraction coupling
5.11. Myocardial proteins
5.12. Contractile function
6. GENETIC ENGINEERING
7. CARDIAC PACING, general
7.1. Pacing, bifocal
7.2. Antitachycardia
7.3. Pacemacker technology
8. CARDIOVASCULAR DISEASE IN PREGNANCY
9. CARDIOVASCULAR DISEASE IN ELDERLY
10. CARDIOVASULAR NURSING
11. CARDIOVASCULAR PATHOPHYSIOLOGY
12. CARDIOVASCULAR PATHOPHYSIOLOGY,general
13. CARDIOVASCULAR SURGERY
13.1. Coronary artery disease
13.2. Congenital heart disease
13.3. Valvular disease
13.4. Antitachycardia, surgery
13.5. Intensive care
13.6. Cardiac Transplantation
13.7. Heart, artificial
13.8. Myocardial protection, clinical
13.9. Associated complications
13.10. Support devices
14. CELLULAR ELECTROPHYSIOLOGY (basic research)
15. COMPUTERS IN CARDIOLOGY
15.1. Image processing
15.2. Diagnostic ECG
15.3. Ambulatory ECG
15.4. ECG mapping
15.5. Medical decision making
15.6. Databases
15.7. Signal processing techniques
15.8. Knowledge systems
16. CONGESTIVE HEART FAILURE, general
16.1. Metabolism
16.2. Experimental
16.3. Neural mechanisms
16.4. Peripheral circulation
16.5. Myocardial function
16.6. Hypertrophy
16.7. Diagnosis
16.8. Prognosis
16.9. Treatment
17. CORONARY CIRCULATION
17.1. Coronary artery disease, general
17.2. Coronary circulation, experimental studies
17.3. Angina pectoris, stable or unstable
17.4. Coronary vasospasm
17.5. Myocardial ischaemia
17.6. Coronary flow, techniques/results
17.7. Coronary flow reserve
17.8. Quantitative coronary angiography
17.9. Angiocradiograhpy
17.10. Kawasakis disease
18. DEVELOPMENTAL ANATOMY & PATHOLOGY
19. DRUG THERAPY
19.1. Pharmacology, general
19.2. Pharmacokinetics
19.3. Drug interactions
19.4. Adrenergic receptor agonists & antagonists
19.5. Adrenergic receptor agonists & antagonists
19.6. Antithypertensive agents, general
19.7. ACE inhibitors
19.8. Calcium channel blockers, general
19.9. Calcium channel blockers, angina pectoris
19.10. Digitalis
19.11. Diuretics, general
19.12. Drugs, genetic techniques
19.13. Inotropic agents
19.14. Nitrates
19.15. Cardiac receptors
19.16. Lipid-lowering drugs
19.17. Anti-ischaemic drugs
20. ECHOCARDIOGRAPHY, general
20.1. Doppler
20.2. Colour Doppler
20.3. Stress echo
20.4. Transoesophageal (TEE)
20.5. Contrast echo
20.6. Intravascular echo
21. EPIDEMIOLOGY & PREVENTION, general
21.1. Arteriosclerosis
21.2. Lipids
21.3. Coronary heart disease, MI
21.4. Interventions
21.5. Health education
21.6. Prevention, cardiovascular disease
21.7. Prognosis, general
21.8. Cardiomyopathy
21.9. Hypertension
21.10. Congestive Heart Failure
22. CARDIOVASCULAR DISEASE IN WOMEN
23. EXERCISES TESTING, general
23.1. in coronary artery disease
23.2. in valvular & congenital heart disease
23.3. in congestive heart-failure
24. GROWN UP CONGENITAL HEART DISEASE,general
25. HYPERTENSION, general
25.1. Experimental
25.2. ACE-system
25.3. Atrial natriuretic peptide (factor)
25.4. Autonomic nervous system
25.5. Blood pressure mechanisms
25.6. Diuretics, hypertension
25.7. Hypertension, the heart in
25.8. Endothelial factors
25.9. Hypertension, secondary
25.10. Haemodynamics
25.11. Hormones, electrolytes, membranes
25.12. Treatment
25.13. Ambulatory blood pressure
25.14. Renin-angiotensin-aldosterone system
25.15. Children and adolescents
26. INTERVENTIONAL CARDIOLOGY, general
26.1. Coronary balloon angioplasty, general
26.2. Angioplasty, restenosis
26.3. Coronary atherectomy (excisional, rotational, extracting)
26.4. Coronary laser angioplasty
26.5. Coronary stenting
26.6. Coronary angioplasty, new devices
26.7. Angioscopy, coronary intravascular ultrasound
26.8. LV assistance during coronary angioplasty
27. MICROCIRCULATION
28. MYOCARDIAL FUNCTION, general
29. MYOCARDIAL INFARCTION, general
29.1. Mechanisms & physiopathology
29.2. Acute phase
29.3. Post infarction period
29.4. Prognosis
29.5. Thrombolysis
29.6. Coronary angioplasty in MI
29.7. CCU
30. MYOCARDIAL & PERICARDIAL DISORDERS, general
30.1. Toxic
30.2. Cardiomyopaty, general
30.3. Dilated cardiomyopathy
30.4. Hypertrophic cardiomyopathy
30.5. Pericardial diseas
30.6. Vasculitis
30.7. Tumours y
30.8. Myocarditis
30.9. Biopsy
30.10. Prognosis
30.11. Virus
30.12. Immunological
30.13. Infiltrative
30.14. Endomyocardial disease
31. NUCLEAR CARDIOLOGY & MRI, general
31.1. Scintigraphy
31.2. Positron emission tomography (PET)
31.3. Magnetic resonance imaging/spectroscopy
32. PAEDIATRIC CARDIOLOGY, general
33. PATHOGENESIS OF ATHEROSCLEROSIS (basic research), general
33.1. Models
33.2. Lipids
33.3. Free radicals
33.4. Molecular biology
33.5. Cell proliferation & growth factors
33.6. Progression/Regression of atherosclerosis
34. PERIPHERAL CIRCULATION, general
34.1. Angiography
34.2. Laser
34.3. PTA
34.4. Atherectomy, peripheral
34.5. Venous disease
34.6. Arteritis
34.7. Vasospasm
34.8. Aneurysm
34.9. Carotid Artery
34.10. Takayasu disease
35. PULMONARY CIRCULATION, general
35.1. Cor pulmonale
35.2. Hypertension, pulmonary
35.3. Pulmonary disease
35.4. Pulmonary embolism
36. REHABILITATION, general
37. SOCIO-ECONOMIC ASPECTS OF CARDIOLOGY, general
37.1. Management
37.2. Economics
37.3. Audit
37.4. Legal aspects
37.5. Ethical aspects
37.6. Certification
37.7. Organisation of education
37.8. Iatrogenic disorders
38. STROKE
39. THROMBOSIS & PLATELETS, general
39.1. Anticoagulant drugs & therapy
39.2. Antiplatelet agents & therapy
39.3. Antithrombotic agents & therapy
39.4. Thrombolytic agents & therapy
39.5. Thrombo-embolic diseases
39.6. Platelets & thrombosis
40. VALVULAR HEART DISEASE, general
40.1. Aortic valve disease
40.2. Mitral valve disease
40.3. Mitral valve prolapse
40.4. Pulmonary valve disease
40.5. Tricuspid valve disease
40.6. Complications
40.7. Endocarditis
40.8. Valvular allo-prostheses
40.9. Bioprostheses
40.10. Valvuplasty
41. RHEUMATIC FEVER, general
42. CHAGASS DISEASE, general
|